Gas power plant to come up in Afghanistan

Article

Bayat Power, the power production division of Bayat Energy Afghanistan's largest Afghan-owned Energy Exploration, Development and Production Company, has announced that the Government of The Islamic Republic of Afghanistan (GIRoA), provided final approval for the construction of Bayat Power-1, Bayat Power's 

Gas

-to Electricity Power Plant, which will be located in Sheberghan, the capital city of Jowzjan Province.

The Bayat Power-GIRoA PPA, authorizes the sale of 40 MW of electrical generation capacity —enough power for 1,000,000 Afghans and businesses—from the Bayat Power-1 Plant to The Government of Afghanistan. The electric power generated from Bayat Power-1 will be distributed through Da Afghanistan Breshna Sherkat  (DABS), Afghanistan's National Power Company.

The approval of The Bayat Power-1 Power plant, together with Bayat Power's Power Purchase Agreement with the Government of Afghanistan—the first ever 

Gas

 to Power PPA concluded between an Afghan-owned energy producer and the Afghan government—provides both parties with important advantages, including:

  • The development of an Afghan-owned energy exploration, production, generation and distribution sector, which will strengthen Afghanistan's energy self-sufficiency.
  • A long term, recurring revenue stream for The Government of Afghanistan, through the sale of natural gas.
  • The provision of electric power that is stable, scalable and affordable to the people of Afghanistan.

Bayat Power-1 will generate power using a series of advanced Siemens SGT-45 mobile 

turbines

, which are designed and manufactured in Houston, Texas.

"This final approval for the construction of Bayat Power-1, together with the execution of our Power Purchase Agreement with the Government of Afghanistan means that we can now provide power to an additional 1,000,000 Afghans and businesses," said Dr. Ehsan Bayat, the Founder of Bayat Power and the Chairman of The Bayat Group.

Recent Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.